Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH)
Yıl: 2021 Cilt: 58 Sayı: 4 Sayfa Aralığı: 255 - 256 Metin Dili: Türkçe DOI: 10.29399/npa.28019 İndeks Tarihi: 30-12-2021
Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH)
Öz: -
Anahtar Kelime: Phosphorylated Neurofilament Heavy Chain (pNFH) in Clinically Isolated Syndrome and Multiple Sclerosis
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editoryal Erişim Türü: Erişime Açık
- 1. Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science 1998;279:514–519.
- 2. Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 2018;14:577–589.
- 3. Gordon BA. Neurofilaments in disease: what do we know? Curr Opin Neurobiol 2020;61:105–115.
- 4. Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius Å, Liman V, Norgren N, Blennow K, Zetterberg H. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med 2016;54:1655–1661.
- 5. Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, KoelSimmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 2009;72:1322–1329.
- 6. Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cermeño JC, Picón C, Kuhle J, Disanto G, Kappos L, Sastre-Garriga J, Pareto D, Simon E, Comabella M, Río J, Nos C, Tur C, Castilló J, Vidal-Jordana A, Galán I, Arévalo MJ, Auger C, Rovira A, Montalban X, Tintore M. Neurofilament light chain level is a weak risk factor for the development of MS. Neurology 2016;87:1076–1084.
- 7. Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis. Mult Scler 2019;25:678– 686.
- 8. Oeckl P, Jardel C, Salachas F, Lamari F, Andersen PM, Bowser R, de Carvalho M, Costa J, van Damme P, Gray E, Grosskreutz J, Hernández-Barral M, Herukka SK, Huss A, Jeromin A, Kirby J, Kuzma-Kozakiewicz M, Amador Mdel M, Mora JS, Morelli C, Muckova P, Petri S, Poesen K, Rhode H, Rikardsson AK, Robberecht W, Rodríguez Mahillo AI, Shaw P, Silani V, Steinacker P, Turner MR, Tüzün E, Yetimler B, Ludolph AC, Otto M. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph Lateral Scler Frontotemporal Degener 2016;17:404–413.
- 9. Uzunköprü C, Yüceyar N, Güven Yılmaz S, Afrashi F, Ekmekçi Ö, Taşkıran D. Retinal Nerve Fiber Layer Thickness Correlates with Serum and Cerebrospinal Fluid Neurofilament Levels and is Associated with Current Disability in Multiple Sclerosis. Arch Neuropsychiatr 2021;58:34–40.
- 10. Won JH, Ahn KH, Back MJ, Ha HC, Jang JM, Kim HH, Choi SZ, Son M, Kim DK. DA-9801 promotes neurite outgrowth via ERK1/2-CREB pathway in PC12 cells. Biol Pharm Bull 2015;38:169–178.
- 11. Silber E, Semra YK, Gregson NA, Sharief MK. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 2002;58:1372–1381.
| APA | Tuzun E, Şanlı E, Akbayır E, Türkoğlu R (2021). Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). , 255 - 256. 10.29399/npa.28019 |
| Chicago | Tuzun Erdem,Şanlı Elif,Akbayır Ece,Türkoğlu Recai Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). (2021): 255 - 256. 10.29399/npa.28019 |
| MLA | Tuzun Erdem,Şanlı Elif,Akbayır Ece,Türkoğlu Recai Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). , 2021, ss.255 - 256. 10.29399/npa.28019 |
| AMA | Tuzun E,Şanlı E,Akbayır E,Türkoğlu R Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). . 2021; 255 - 256. 10.29399/npa.28019 |
| Vancouver | Tuzun E,Şanlı E,Akbayır E,Türkoğlu R Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). . 2021; 255 - 256. 10.29399/npa.28019 |
| IEEE | Tuzun E,Şanlı E,Akbayır E,Türkoğlu R "Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH)." , ss.255 - 256, 2021. 10.29399/npa.28019 |
| ISNAD | Tuzun, Erdem vd. "Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH)". (2021), 255-256. https://doi.org/10.29399/npa.28019 |
| APA | Tuzun E, Şanlı E, Akbayır E, Türkoğlu R (2021). Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). Nöropsikiyatri Arşivi, 58(4), 255 - 256. 10.29399/npa.28019 |
| Chicago | Tuzun Erdem,Şanlı Elif,Akbayır Ece,Türkoğlu Recai Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). Nöropsikiyatri Arşivi 58, no.4 (2021): 255 - 256. 10.29399/npa.28019 |
| MLA | Tuzun Erdem,Şanlı Elif,Akbayır Ece,Türkoğlu Recai Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). Nöropsikiyatri Arşivi, vol.58, no.4, 2021, ss.255 - 256. 10.29399/npa.28019 |
| AMA | Tuzun E,Şanlı E,Akbayır E,Türkoğlu R Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). Nöropsikiyatri Arşivi. 2021; 58(4): 255 - 256. 10.29399/npa.28019 |
| Vancouver | Tuzun E,Şanlı E,Akbayır E,Türkoğlu R Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH). Nöropsikiyatri Arşivi. 2021; 58(4): 255 - 256. 10.29399/npa.28019 |
| IEEE | Tuzun E,Şanlı E,Akbayır E,Türkoğlu R "Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH)." Nöropsikiyatri Arşivi, 58, ss.255 - 256, 2021. 10.29399/npa.28019 |
| ISNAD | Tuzun, Erdem vd. "Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH)". Nöropsikiyatri Arşivi 58/4 (2021), 255-256. https://doi.org/10.29399/npa.28019 |
